The former president of e-mail outsourcer Critical Path Inc. has pleaded guilty to securities fraud, saying he conspired to falsely report the company’s revenue for the third and fourth quarters of ...
TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B.
News-Medical.Net on MSN
A longitudinal guide to early Parkinson’s progression
Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of Neurology that offers critical longitudinal insights into how symptoms and functional impacts evolve for ...
TUCSON, Ariz., March 26, 2024 — Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) Consortium. The CPA-1 consortium aims ...
Critical Path Institute's ® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment for type 1 diabetes (T1D). Kyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results